Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ductal Carcinoma|Invasive Breast Carcinoma|Invasive Ductal Breast Carcinoma
Interventions: BIOLOGICAL: Talimogene laherparepvec|DRUG: Paclitaxel
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Amgen